Kostaive

Zapomeran, the active ingredient in Kostaive, is a pharmaceutical compound presented as an injectable solution for intramuscular use. It is intended for investigational or clinical study purposes.\n\nGNH India supplies Kostaive as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Zapomeran is an investigational agent studied in the context of inflammatory and immune‑mediated conditions.

Common Side Effects:\n- None reported in available clinical data.\n\nSerious or Rare Side Effects:\n- No serious adverse reactions have been documented in the limited public information on Zapomeran.

Pregnancy: Safety has not been established; use only if clearly needed.\nBreastfeeding: Potential effects unknown; caution advised.\nRenal impairment: Use with clinical monitoring.\nHepatic impairment: Use with clinical monitoring.\nAllergic reactions: Monitor for signs of hypersensitivity.\nStore at ambient temperature: Keep in original container, protect from moisture and direct sunlight.

Major Interactions (Avoid):\n- No identified major drug interactions in current literature.\n\nModerate Interactions (Monitor Closely):\n- Concomitant immunosuppressants may require clinical monitoring.\n- Coadministration with vaccines could theoretically affect immune response; observe patient closely.\n- Potential interaction with agents affecting hepatic metabolism; monitor liver function tests.